Company / PP&E (Net)
Evolent Health, Inc. PP&E (Net) History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest PP&E (Net)
$80.8M
FY2025
5-year range
$73.2M / $87.9M
FY2021-FY2025
Trend
+10.4%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
PP&E (Net) returned to growth in FY2025 after 2 years of decline, reaching $81M.
Based on SEC 10-K filings.
$81M in FY2025 with a 5-year CAGR of -1.3%.
Improved from $78M to $81M over the past 2 years.
PP&E (Net) over time
Growth rates
- 3-Year CAGR
- -2.8%
- 5-Year CAGR
- -1.3%
- 10-Year CAGR
- -
Key checks
Key Insights
- 5-year CAGR of -1.3%, indicating a declining trend.
- In FY2025, pp&e (net) increased 10.4% year-over-year.
- Peak pp&e (net) was recorded in FY2022.
- Lowest pp&e (net) in the period was in FY2016.
Company context
Key Data Points
- Altman Z-Score -0.84 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | PP&E (Net)Value | YoY GrowthYoY |
|---|---|---|
| FY2025 | $80.8M | +10.4% |
| FY2024 | $73.2M | -6.4% |
| FY2023 | $78.2M | -11.0% |
| FY2022 | $87.9M | +8.0% |
| FY2021 | $81.4M | -5.7% |
| FY2020 | $86.2M | +1.3% |
| FY2019 | $85.2M | +15.7% |
| FY2018 | $73.6M | +44.6% |
| FY2017 | $50.9M | +63.3% |
| FY2016 | $31.2M | - |
As of FY2025 · SEC Form 10-K · Last checked Jun 21, 2026